Collaboration with Concarlo Therapeutics

Anyo Labs enters a collaboration with Concarlo Therapeutics, a leader in precision oncology based in Brooklyn, New York. This collaboration utilizes Anyo’s iterative scaffold substitution optimization to address critical oncological targets, aligning with Concarlo’s expertise in drug-resistant cancers.

Concarlo is dedicated to developing transformative therapies for conditions such as metastatic breast cancer, targeting the CDK4/CDK6 and CDK2 pathways to overcome resistance. In this project, Anyo will support Concarlo’s efforts to enhance the efficacy of their lead compound and explore new therapeutic opportunities within their pipeline.

This partnership underscores Anyo’s engagement in advancing drug discovery through strategic collaborations, bringing together our scientific capabilities with Concarlo’s innovative approach to meet unmet needs in oncology. We are dedicated to delivering impactful solutions for more effective drug discovery.